The board of Venus Medtech (Hangzhou) Inc. announced that, Mr. Fei Wang has been appointed as the Chief Financial Officer with effect from January 4, 2024. Fei Wang, aged 46, has over 20 years of experience in finance and strategic planning. Mr. Wang previously served as the chief financial officer of 3SBio Inc. from April 2020 to April 2023.

Before that, Mr. Wang worked at AstraZeneca, as the chief financial officer of its China operation from January 2011 to October 2015 and as the director of finance of its respiration, immunology and inflammation department from January 2020 to April 2020. He served as an executive director and as chief financial officer of a Hong Kong listed company from March 2018 to December 2019. Mr. Wang received a bachelor's degree in management from Xinjiang University of Finance and Economics in 1999 and an MBA from Shanghai Jiao Tong University and Euromed Marseille Ecole de Management (now known as KEDGE) in 2012.

Mr. Wang is a certified public accountant in the PRC.